Can You Truly Lower Your Biological Age? An Evidence-Based Review

The short answer

While the concept of 'lowering biological age' is appealing, the current evidence suggests that sustained, significant reversal of established biological age, as measured by epigenetic clocks, is not yet definitively proven or widely achievable. Lifestyle interventions can influence these metrics, but the extent of true biological 'reversal' versus slowing the pace of aging remains an active area of research.

What the evidence actually shows

Biological age refers to an individual's physiological state relative to their chronological age, often estimated using 'epigenetic clocks' based on DNA methylation patterns (e.g., Horvath clock, GrimAge, PhenoAge). These clocks have shown strong correlations with healthspan, disease incidence, and mortality (Horvath et al., Genome Biology, 2013; Levine et al., Aging, 2018). The ability to 'lower' biological age implies reversing these epigenetic marks. A landmark, albeit small, human trial demonstrated a modest reversal (average 2.5 years) of biological age using a combination of growth hormone, DHEA, and metformin over one year (Fahy et al., Aging Cell, 2019). This study, however, was uncontrolled and involved a complex intervention, making specific attribution difficult. Other observational studies suggest that healthy lifestyle factors like exercise, diet, and stress reduction are associated with a slower pace of epigenetic aging or a 'younger' biological age, but these are correlations, not direct causal interventions for reversal (Peters et al., Nature Medicine, 2015).

“The epigenetic clock is a robust biomarker of aging that can predict age-related health outcomes and mortality.”

— Horvath et al., Genome Biology 2013

Where Harvard Health gets it right

Harvard Health often rightly emphasises foundational lifestyle practices for healthy aging, which indirectly align with slowing biological aging. They correctly highlight the importance of a balanced diet rich in whole foods, regular physical activity, adequate sleep, and stress management. These interventions are well-supported by extensive epidemiological and interventional research for their benefits on chronic disease prevention and overall longevity. While Harvard might not explicitly endorse 'reversing' biological age, their advice on improving markers of health, such as blood pressure, glucose control, and inflammatory markers, aligns with factors that contribute to a healthier epigenetic profile and a slower rate of aging, as indicated by various biological clocks.

Where the evidence is more nuanced

Harvard Health, like many popular outlets, can sometimes oversimplify the concept of biological age and the efficacy of interventions. The Fahy et al. (2019) study, often cited as proof of biological age reversal, was a small, unblinded trial without a control group, making its conclusions highly preliminary and not generalisable. Furthermore, the precise clinical significance of a few years' 'reversal' on an epigenetic clock is not fully understood. It's unclear if this translates to tangible improvements in healthspan or just a change in a biomarker. Many claims about specific supplements or extreme diets 'reversing' biological age lack robust human trial data, relying instead on associations or mechanistic speculation. The field is still maturing, and definitive, large-scale randomised controlled trials are largely absent.

Practical implications

For individuals seeking to optimise their healthspan, the most evidence-backed approach remains a holistic focus on lifestyle. This includes adopting a nutrient-dense diet (e.g., Mediterranean-style), engaging in regular moderate-to-vigorous physical activity, prioritising 7-9 hours of quality sleep, managing chronic stress through practices like mindfulness, and avoiding harmful exposures such as smoking and excessive alcohol. While the promise of 'reversing' biological age is compelling, current strategies should focus on slowing the *rate* of aging and mitigating age-related diseases through these established health behaviours, rather than chasing unproven quick fixes based on preliminary biomarker shifts.

Where reasonable people still disagree

• The clinical significance of a measured 'reversal' in epigenetic age: Does a shift of a few years on a clock translate to tangible health benefits?
• The reliability and specificity of different epigenetic clocks: Which clock is the most accurate predictor of healthspan and mortality, and which is most responsive to interventions?
• The role of specific pharmaceutical interventions (e.g., metformin, rapamycin) in influencing biological age in healthy humans: Are observed effects truly causative and beneficial, or merely correlative?